| Walgreen #10431 | |
| 201 Wb Mclean Dr, Cape Carteret, North Carolina 28584 | |
| (252) 393-2031 |
| Name | Walgreen #10431 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 201 Wb Mclean Dr, Cape Carteret, North Carolina 28584 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (252) 393-2031 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Despite the common clinical practice among surgeons to discontinue their patients' anti-platelet therapy prior to surgery, a recent study of patients undergoing carotid endarterectomy (CEA) indicated that this practice may be unnecessary.
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.
The changing medical needs of the growing 65-and-over population in the United States are not being met by current medical education, University of Cincinnati (UC) researchers warn.
Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| NPI Number | 1760664460 |
| Organization Name | WALGREEN CO. |
| Doing Business As | WALGREENS #10431 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 201 Wb Mclean Dr, Cape Carteret, NC 28584 |
| Phone Number | 252-393-2031 |
News Archive
Despite the common clinical practice among surgeons to discontinue their patients' anti-platelet therapy prior to surgery, a recent study of patients undergoing carotid endarterectomy (CEA) indicated that this practice may be unnecessary.
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.
The changing medical needs of the growing 65-and-over population in the United States are not being met by current medical education, University of Cincinnati (UC) researchers warn.
Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
News Archive
Despite the common clinical practice among surgeons to discontinue their patients' anti-platelet therapy prior to surgery, a recent study of patients undergoing carotid endarterectomy (CEA) indicated that this practice may be unnecessary.
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.
The changing medical needs of the growing 65-and-over population in the United States are not being met by current medical education, University of Cincinnati (UC) researchers warn.
Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
Walgreen #10431 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 201 Wb Mclean Dr, Cape Carteret, North Carolina 28584 Phone: (252) 393-2031 |